Tag: Khiron
Khiron receives its largest European medical cannabis shipment to date
Khiron’s largest shipment to date of EU-GMP certified medical cannabis product arrives in Germany Khiron…
Khiron Life Sciences Reports First Quarter 2021 Financial Results
Record revenues of $2.8 million in Q1 2021, a 49% increase from the prior year…
Khiron to Host First Quarter 2021 Conference Call on May 28, 2021
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a…
Khiron Life Sciences Reports 2020 Fiscal Year End Results and Provides Corporate Update
Generated 31% sequential quarter-on-quarter growth in Q4 2020, driven by normalized clinic operations and more…
Khiron Receives Accreditation for UK Medical Cannabis Education and Partners with UK’s Cellen Therapeutics to Improve Clinician Education
Company has received UK Continuing Professional Development (“CPD”) accreditation for its global education platform, Khiron…
Khiron Expands Product Offering in UK and Increases Patient Access
Following successful medical cannabis launch in Germany, Khiron 1/14, a high CBD flower is expected…
Khiron Medical Cannabis Products Arrive in Germany for Immediate Prescription, Sale and Distribution
First shipment of Khiron branded EU-GMP certified medical cannabis to Germany successfully completed, providing immediate access to…
Khiron Becomes First Colombian Medical Cannabis Company to Export Live Cannabis Clones to Europe
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a…
Khiron and Tecnologico de Monterrey of Mexico Launch First Internationally Accredited Medical Cannabis Diploma in Latin America
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a…
Khiron Announces Expansion of Small-Format Zerenia Clinics in Colombia Following Success of Initial Launch
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a…
Recent Comments